MHRA Approved · June 2026 · Novo Nordisk
Wegovy Tablets (Coming Soon)
Once-daily oral semaglutide tablets — the weight loss tablet that's changing everything
- Once-daily oral semaglutide tablet — same active ingredient as the Wegovy injection, now in tablet form
- Clinically proven — participants lost up to 22% of body weight after 64 weeks (OASIS 4 trial)
- Available in four tablet strengths: 1.5mg, 4mg, 9mg, and 25mg
- No needles, no sharps bin, no refrigeration required
- Made by Novo Nordisk — the manufacturer of Wegovy injections and Ozempic
- MHRA-approved on 11 June 2026 — expected to be available July 2026
Pharmacy
Required
Only
Registering your interest doesn't place an order or reserve a dose. Once stock arrives, we'll email you so you can decide whether to book a consultation. Wegovy tablets are a prescription-only medicine.
Simple Process
How Ordering Your Wegovy Tablets Works
Register Your Interest
Sign up for our stock notification and we'll email you the moment Wegovy tablets arrive at Weldricks. No payment needed — just your email address.
We'll Let You Know
As soon as stock arrives, we'll send you an email with everything you need to know — including pricing, strengths available, and how to get started.
Book Your Consultation
When you're ready, complete a short online consultation reviewed by one of our pharmacists. If approved, we'll dispense and dispatch your Wegovy tablets with free tracked delivery in discreet packaging.
OASIS 4 Clinical Trial Data
What the Clinical Evidence Shows
Data from the OASIS 4 clinical trial (Novo Nordisk, 2026). Individual results will vary. Clinical results were achieved alongside diet and exercise guidance.
What Is the Wegovy Tablet?
The Wegovy tablet is a once-daily oral semaglutide tablet — containing the same active ingredient found in the Wegovy injection. It was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) on 11 June 2026, making it the first oral GLP-1 receptor agonist licensed for weight management in the UK.
Manufactured by Novo Nordisk (the same company behind Wegovy injections, Ozempic, and Rybelsus), the Wegovy tablet works by mimicking the GLP-1 hormone your body naturally produces. It activates receptors in the brain to reduce hunger, increase feelings of fullness, and slow how quickly food leaves your stomach — helping you feel satisfied on less food.
How Does the Wegovy Tablet Work?
You might wonder how a tablet can deliver semaglutide when your stomach would normally break it down before it can be absorbed. The answer is clever science: the semaglutide in Wegovy tablets is combined with a carrier molecule called SNAC (sodium N-[8-(2-hydroxybenzoyl) amino] caprylate), which protects it just long enough to be absorbed through the stomach lining and into the bloodstream. Once there, it works exactly like the injection.
For best results, Wegovy tablets must be taken first thing in the morning on an empty stomach, with no more than 120ml of plain water, and you must wait at least 30 minutes before eating, drinking, or taking other medicines.
Is the Wegovy Tablet the Same as Rybelsus?
Both are oral semaglutide tablets made by Novo Nordisk, but they are different products with different licences. Rybelsus is licensed for type 2 diabetes management and is available in doses up to 14mg. Wegovy tablets are licensed specifically for weight management and include a higher 25mg maintenance dose not available in Rybelsus. Some people refer to these as the Wegovy pill — but they are the same product.
Wegovy Tablet Dosing Schedule
Like all GLP-1 weight loss treatments, Wegovy tablets use a gradual dose titration — you start low and increase slowly to allow your body to adjust and minimise side effects. Your pharmacist will advise when it's appropriate to move to the next dose based on your progress and tolerance.
| Dose | When | Duration | Price (30 tablets) |
|---|---|---|---|
| 1.5mg | Starting dose — Month 1 | Days 1–30 | Confirmed at launch |
| 4mg | Month 2 | Days 31–60 | Confirmed at launch |
| 9mg | Month 3 | Days 61–90 | Confirmed at launch |
| 25mg | Maintenance — Month 4 onwards | Day 91 onwards | Confirmed at launch |
Switching from the Wegovy Injection to the Tablet
If you are already using the Wegovy injection and want to switch to the daily tablet, our pharmacists can guide you through this. The process below applies to those stabilised on the maximum 2.4mg weekly injection. If you are on a lower dose, your pharmacist will match you to the appropriate introductory tablet strength instead.
Administer your final weekly 2.4mg Wegovy injection exactly as scheduled.
Observe the standard 7-day gap. The injected semaglutide will slowly clear your system at its normal rate.
On the day you would normally take your next injection, do not use the pen. Instead, take your first 25mg Wegovy tablet first thing in the morning, beginning your new daily fasting routine.
This guide is for informational purposes only. Wegovy is a prescription-only medicine. To see if you are eligible, please complete our online medical consultation. Information sourced from the Wegovy Summary of Product Characteristics (eMC).
Available Strengths
Wegovy Tablet Doses at Weldricks
Wegovy tablets are available in four strengths, following a gradual dose titration. Pricing will be confirmed at launch — register your interest now and we'll be in touch the moment stock arrives.
Wegovy tablets are a prescription-only medicine and require a pharmacist-reviewed consultation before supply. All doses are subject to availability at launch.
Am I Eligible?
Wegovy Tablet Eligibility
Wegovy tablets follow the same eligibility criteria as Wegovy injections. All patients must complete an online consultation reviewed by a Weldricks pharmacist before treatment can be approved.
✅ You may be eligible if you…
- Have a BMI of 30 or above
- Have a BMI of 27 or above with a weight-related health condition (e.g. type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea)
- Are aged 18 or over
- Are committed to lifestyle changes alongside treatment (diet and exercise)
- Are not pregnant or breastfeeding
- Are currently using Wegovy injections and wish to switch to the tablet form
❌ You should not take Wegovy pills if you…
- Are allergic to semaglutide or any ingredient in Wegovy
- Have a personal or family history of medullary thyroid carcinoma (MTC)
- Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Are pregnant, planning to become pregnant, or breastfeeding
- Have had a serious allergic reaction to semaglutide previously
This is not a complete list. Our pharmacists will review your full medical history during your consultation. Please tell us about all medicines you take, including over-the-counter treatments and supplements.
How to Take the Wegovy Tablet
- Take first thing in the morning, on an empty stomach, before eating, drinking (other than plain water), or taking any other oral medication.
- Swallow whole with up to 120ml of plain still water. Do not use sparkling water, juice, coffee, tea, or other drinks.
- Wait at least 30 minutes before eating, drinking anything other than water, or taking other medicines. This is critical for proper absorption.
- Do not crush, chew, or split the tablet — it must be swallowed whole.
- Take it at the same time every day to build a consistent routine.
What If I Miss a Dose?
If you miss a dose, skip it and take your next tablet the following morning as normal. Do not take a double dose to make up for the one you missed. If you miss several doses in a row, contact your pharmacist before continuing.
Wegovy Tablet Side Effects
Like all medicines, Wegovy tablets can cause side effects. They are most common when you first start treatment or after a dose increase, and usually improve as your body adjusts.
Common side effects (may affect more than 1 in 10 people):
Wegovy Tablets vs Other Weight Loss Treatments
Not sure which treatment is right for you? Here's how the Wegovy tablet compares to other options available at Weldricks Pharmacy:
| Feature | Wegovy Tablet | Wegovy Injection | Mounjaro Injection | Orlistat |
|---|---|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide | Tirzepatide | Orlistat |
| How to Take | Once-daily tablet | Once-weekly injection | Once-weekly injection | 3× daily capsule with meals |
| Weight Loss (Trial Data) | Up to 22% (64 wks) | Avg. 21% (72 wks) | Avg. 22.5% (72 wks) | Approx. 5–10% |
| Needles Required? | No | Yes | Yes | No |
| Refrigeration? | No | Yes | Yes | No |
| Starting Price | Confirmed at launch | From £99/month | From £149/month | From £27/month |
| Available Now? | Coming soon — register for stock alerts | Yes — available now | Yes — available now | Yes — available now |
Weight loss figures are from published clinical trials and represent averages or peak responder data. Individual results vary. All prices include consultation and prescription.
Content on this page has been written with reference to published clinical trial data (OASIS 4, Novo Nordisk) and MHRA product information. Weldricks Pharmacy is registered with the General Pharmaceutical Council (GPhC No. 1091175).